Article: Cephalon and Eurand sue Mylan and Barr over generic Amrix.

The USA's Cephalon and Dutch firm Eurand have commenced a law suit in the District Court of Delaware against generic drugmakers Mylan and Barr Laboratories regarding the latter two companies' Abbreviated New Drug Applications for two versions of the muscle relaxant Amrix (cyclobenzaprine HCl) extended-release capsules, used as adjunct in the treatment of acute musculoskeletal conditions. Cephalon and Eurand claim the ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!